Carbidopa And Levodopa Tablet, Extended Release
Product Images NDC 50228-460

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Carbidopa And Levodopa (NDC 50228-460). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sciegen Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carbidopa-levodopa Extended Release Tablets-anda (Cls Tabs 25mg 100mg Container Label 1000s)

Label for Carbidopa and Levodopa extended-release tablets, USP, 25 mg/100 mg strength. The label indicates a package of 1,000 tablets, for Rx only, manufactured by ScieGen Pharmaceuticals Inc. Dosage and storage information are provided along with the NDC code 50228-460-10.*

FDA Label Image

Carbidopa-levodopa Extended Release Tablets-anda (Cls Tabs 25mg 100mg Container Label 100s)

Label of Carbidopa and Levodopa Extended-Release Tablets, USP showing strength of 25 mg/100 mg per tablet. The package contains 100 tablets, labeled for Rx only. The label includes usage directions, storage instructions, manufacturer information (ScieGen Pharmaceuticals Inc.), and a barcode.*

FDA Label Image

Carbidopa-levodopa Extended Release Tablets-anda (Cls Tabs 25mg 100mg Container Label 30s)

Label for Carbidopa and Levodopa Extended-Release Tablets, USP 25 mg/100 mg by ScieGen Pharmaceuticals Inc. The label states each tablet contains 25 mg carbidopa and 100 mg levodopa. The package includes 30 tablets. Additional information includes storage instructions, dosage note, and manufacturer details in Hauppauge, NY.*

FDA Label Image

Carbidopa-levodopa Extended Release Tablets-anda (Cls Tabs 50mg 200mg Container Label 1000s)

Label for Carbidopa and Levodopa extended-release tablets, USP with a strength of 50 mg/200 mg. The tablet count is 1,000, and the product is for oral use by prescription only. It is manufactured by ScieGen Pharmaceuticals Inc. The label includes storage instructions, dosage notes, and a barcode.*

FDA Label Image

Carbidopa-levodopa Extended Release Tablets-anda (Cls Tabs 50mg 200mg Container Label 100s)

Label for Carbidopa and Levodopa Extended-Release Tablets, USP 50 mg/200 mg by ScieGen Pharmaceuticals Inc. The label includes dosage form (extended-release tablets), count (100 tablets), and storage instructions. It features a barcode, NDC 50228-461-01, and states Rx only.*

FDA Label Image

Carbidopa-levodopa Extended Release Tablets-anda (Cls Tabs 50mg 200mg Container Label 30s)

Label for Carbidopa and Levodopa Extended-Release Tablets, USP 50 mg/200 mg, oral dosage form by ScieGen Pharmaceuticals Inc. The label shows 30 tablets per container, with usage and storage instructions. It includes the NDC 50228-461-30, barcode, and a reminder for prescription use only.*

FDA Label Image

Carbidopa Chemical Structure (Cls Tabs Carbi Str)

Chemical structure diagram of Carbidopa, one of the active ingredients in the Carbidopa and Levodopa combination drug product by ScieGen Pharmaceuticals Inc.*

FDA Label Image

Levodopa Chemical Structure (Cls Tabs Levo Str)

Chemical structure diagram showing the molecular structure of the active ingredient Levodopa in Carbidopa and Levodopa extended-release tablets by ScieGen Pharmaceuticals Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.